Edited by: Jan I. Olofsson, Karolinska Institutet (KI), Sweden
Reviewed by: Evangelia Elenis, Uppsala University Hospital, Sweden
Milan Milenkovic, University of Gothenburg, Sweden
*Correspondence: Angela Vidal,
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Cesarean sections are becoming more common worldwide. One of the long-term complications of cesarean section is a cesarean scar defect or isthmocele. The presence of isthmocele is associated with infertility.
This systematic review and meta-analysis examined the effect of laparoscopic isthmocele repair on the reproductive outcomes of patients with and without infertility.
We searched MEDLINE, EMBASE, and the Cochrane CENTRAL databases in April 2024.
The study included cohort studies, case-control studies, and case series reporting reproductive outcomes after laparoscopic isthmocele repair among women with or without diagnosed infertility.
The meta-analysis examined rates of live birth, pregnancy, and miscarriage.
The search identified 866 records and 17 articles were included. Clinical pregnancy rates after isthmocele resection were 62% (95% confidence interval (CI) 54-69%) in women with infertility, compared to 33% (95% CI: 16-57%) in women without infertility and 36% in women with unknown fertility status (36%, 95% CI: 21–55%). Live birth rates were 72% (95% CI: 54–85%) among those with infertility, 78% (95% CI: 46–94%) among those without infertility, and 61% (95% CI: 42–77%) with unknown fertility status. Women with and without infertility had low miscarriage rates of 10% (95% CI: 6–16%) and 7% (95% CI: 3–18%), respectively. The prevalence of co-existing endometriosis was 29% (95% CI: 22–37%). The statistical heterogeneity of the studies ranged from 0 to 86%.
Laparoscopic isthmocele repair has demonstrated the potential to improve reproductive outcomes, specifically in cases where infertility is linked to isthmocele-related factors, such as challenges during embryo transfer or impaired implantation. However, further well-designed multicenter trials must confirm these findings and provide stronger evidence.
香京julia种子在线播放
The prevalence of cesarean deliveries is rising at an alarming rate worldwide (
This increasing cesarean rate is associated with a corresponding increase in short- and long-term complications (
Isthmocele can result in abnormal uterine bleeding, pelvic pain, and ectopic pregnancy (
One of the most relevant consequences is the risk of infertility. Several studies have shown a decrease of 15-40% in pregnancy and live birth rates following cesarean sections (
In recent years, surgical techniques have been developed to treat symptomatic isthmoceles, including laparoscopic excision, resectoscopic, vaginal, and laparotomy repair. Women with isthmocele-associated infertility should be treated individually with a multidisciplinary approach. It has been suggested that isthmocele repair may have a beneficial effect on secondary infertility after cesarean section (
Laparoscopic surgery offers the additional advantage of diagnosing and treating other potential causes of infertility concurrently (
Currently, there is no conclusive evidence in support of the use of these surgical techniques for reproductive purposes. Therefore, this systematic review and meta-analysis aims to evaluate the results of laparoscopic correction of isthmocele among women with and without infertility and to analyze its impact on reproductive outcomes.
The study protocol was registered under the Prospective International Registry of Systematic Reviews, PROSPERO (registry number CRD42024548864). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used (
A systematic literature search was conducted using the Medline, Embase, and Cochrane CENTRAL databases in April 2024. An initial MEDLINE search strategy was developed by a medical information specialist and tested with a list of basic references. After refinement and querying, complex search strategies were established for each information source based on database-specific controlled vocabulary (thesaurus terms/subject headings) and text words. Synonyms, acronyms, and similar terms were included in the text word search. The search was limited to publications from 1946 to the present. The search terms included “isthmocele”, “niche”, “cesarean section”, “laparoscopic repair”, “Rendez-vous”, and “fertility and pregnancy outcome”. We incorporated respective thesaurus terms and used synonyms, acronyms, and similar terms for all concepts in the text word search. Animal-only studies were excluded from the MEDLINE and Embase searches using a double negative search strategy based on Ovid “humans only” filters. The detailed final search strategies are presented as a
Investigators AV, JG, and VV independently assessed studies for inclusion using the Covidence software (Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia,
The extracted data were abstracted and reviewed in detail by three investigators (AV, JG, and VV) independently. Primary variables of interest included study population characteristics such as patient age, cause and duration of infertility, niche size, pre- and post-intervention RMT, duration of follow-up, presence of endometriosis, and reproductive outcomes (conception method, clinical pregnancy rate, miscarriage rate, and live birth rate). Disagreements were discussed and resolved by consensus.
The general focus of this study was on women with a desire to become pregnant and a diagnosis of an isthmocele. The population was divided into three groups. The first group comprised women with infertility. Infertility is internationally defined by the World Health Organization (WHO) as the inability to conceive after 12 months of regular, unprotected sexual intercourse. This definition was adopted for its global reach and for representing a well-established clinical and epidemiological standard, taking into account the discrepancies among the clinical guidelines of the American Society for Reproductive Medicine (ASRM), the National Institute for Health and Care Excellence (NICE), and ESHRE (
Only studies that assess one or more of the following reproductive outcomes were included (
The Newcastle-Ottawa Scale (NOS) was used for the quality assessment of each study (
The primary outcome of our systematic review was the reproductive outcomes (CP, M, LB) after laparoscopic isthmocele repair. For the pooled ORs, statistical analyses were performed with the “metaphor” function of the R software (R Core Team, Vienna, Austria, 2013). Heterogeneity was examined using Cohen’s Q statistic and the I2 statistic. In the presence of high heterogeneity, random-effects models were used.
A total of 3685 citations were identified from searching the databases. Seventy-eight studies remained after screening the abstracts and full text of the study topic. However, we excluded 61 of these studies for failing to meet our pre-specified inclusion criteria. Therefore, 17 articles were included in the systematic review (
PRISMA flow diagram. FLOWCHART of the literature search and selection process. *Consider, if feasible to do so, reporting the number of records identified from each database or register searched (rather than the total number across all databases/registers). **If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools. Source: Page MJ, et al. BMJ 2021;372:n71. doi: 10.1136/bmj.n71. This work is licensed under CC BY 4.0. To view a copy of this license, visit
The characteristics of the study populations are summarized in
Characteristics of the included studies (cohorts and case series).
First author, Year of publication | Country | Study design | Total Study population | Number of participants either with LSC+HSC or LSC only | Age, years (mean ± SD) | Previous number of CS | ART before surgical intervention/Total participants and % | Diagnostic done before surgery and after the surgery | Size of the niche (mm) Mean, SD or median (range) | RMT before intervention (mm) Mean, SD or median (range) | RMT post intervention (mm) Mean, SD or median (range) | Postoperative diagnostic | Recommendation to wait before conceiving after surgery (months) | Duration of follow-up (mo) (range) | Mean time since last CS (months) | Endometriosis | Duration of follow-up (months) (range) | Inclusion criteria for LSC/LSC+HSC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Li et al., 2014 ( |
China | Retrospective study | 41 | 17 (LSC) | 34,8±4 | 1(n=31, davon n=10 Emergency section), 2 (n=10) | NM | TVS+HSC | 11,4 | 2,3 | 9,5 | TVS | NM | 16 | NM | NM | 16 | RMT<3,5mm + |
Donnez et al., 2017 ( |
France | Observational study with prospective evaluation | 38 | 38 (LSC) | 32,6 ±5,6 | 1(n=25), 2(n=12), 3(n=1) | NM | MRT, TVSS; 3 month post-surgery, Immunhisto und Patho | NM | TVS: 1,7±1 median: 1,6 mm, range 0-3,2 mm, MRI 1,4±0,7mm, median: 1,5 mm range 0-2,7 mm | MRI 9,6±1,8mm, median 9,5 mm, range 5-11,6 mm | MRI | 3 | 12-72 | NM | 8/38 (21%) | 72 | RMT < 3mm (MRI). |
Zhang, X. et al., 2016 ( |
China | Prospective study | 142 | 86 (LSC + HSC) | – | NM-min.1 | NM | NM | NM | Not measured | Not measured | 28,6(12-45) | 24 | NM | NM | CSD > 1cm |
||
Delaine et al., 2017 ( |
France | Case Series | 9 | 9 (LSC + HSC) | 35 (28-41) | NM – min.1 | 2/9 (22,2) | TVS/SIS/MRI/HSC/Hormone status | 24x16,5x16 | 1,25 (median – only) available for n=6) | Not measured | Not measured | NM | 28 | 36 (12-84) | 3/9 (33,3%) | 28 | |
Zhang, X. et al., 2017 ( |
China | Retrospective study | 146 | 146 (LSC + HSC) | Complete repair: 26,8±2,8 |
NM – min.1 | NM | TVS, MRI, HSC, Cur, for irregular bleeding (n=43) in the incomplete group and n=98 in the complete group | Complete repair: 10,3±4,2 |
3,8±3,4(incomplete), 3,8±1,7(complete) | Not measured | Not measured | NM | 41,1±11,1 | NM | NM | 41.1 | Symptomatic ishtmocele, |
Lv et al., 2018 ( |
China | Retrospective study | 82 | 30 (LSC+HSC) | 31,2 | NM – min. 1 | NM | TVS | 10,1(6-3) | 0,9(0,1-3,9) | Not measured | Not measured | 12 | 21 (13-36) | 27 | NM | 21 | Min. 1 CS |
Zhang, D. et al., 2019 ( |
China | Retrospective cohort study | 67 | 36(LSC+HSC) | 33,5 | NM – min.1 | NM | TVS | W: 1,4±0,5, L: 0,9±0,3 | 1,81±0,93 | 4,68 | TVS | 12 | NM | 21/67(31) | NM | ||
Zhang, N. et al., 2021 ( |
China | Retrospective Cohort Study | 62 | 27(LSC+HSC) | 32,6 | NM – min.1 | NM | TVS und confirmed with SIS | 8,2x6,8x6,7 | 3,1 | Not measured | Not measured | NM | 18 | NM | NM | 18 | Symptomatic isthmocele |
Zhang, Y. et al., 2020 ( |
China | Retrospective Study | 65 | 45(LSC+HSC) | 30,2±4,4 | 1(n=50), 2(n=14), 3 (n=1) | NM | TVS, MRI | W MRI: 19,3±6,4 |
3,26±2,68 | Effectiveness 95% no specific data available | TVS | NM | NM | NM | NM | NM | |
Karampelas et al., 2021 ( |
Belgium | Retrospective Case series | 31 | 31(LSC) | 34,3(24-48) | NM – min.1 | NM | TVS/SIS/MRI | NM | 1,77±0,86 | 7,8±1,22 | SIS | NM | NM | NM | NM | NM | Symptomatic isthmocele with RMT < 5mm. |
Cardaillac et al., 2023 ( |
France | Retrospective cohort study | 33 | 33(LSC+HSC) | 32,6±3,2 | 1 (n=25), 2(n=7), 3 (n=1) | NM | TVS | NM | 1,5 | 4,26 | TVS | NM | 24 | 4,2±1,2 years | NM | 29 | Isthmocele >20 mm, RMT <3 mm, symptomatic ishtmocele and desire to get pregnant |
Gulz et al., 2022 ( |
Switzerland | Retrospective study | 83 | 83(LSC+HSC) | 34 | NM – min.1 | NM | TVS | NM | NA | Not measured | FU(interview and telephone) | 3 | NM | NM | 19/83(22,8) | NM | Symptomatic ishtmocele |
Jordans et al., 2022 ( |
Netherlands | Prospective cohort study | 100 | 61(LSC+HSC) | 34,5±3,5 | 1(n=49), 2(n=10), 3 (n=2) | NM | TVS | NM | 1(0,6-1,8) | GA 12 - 5,3 (3,8-9,0), GA 20 4,8 (2,7-7,8), 2,2 (1,6 - 4,8) | TVS, niche evaluated |
NM | NM | NM | NM | NM | RMT<3mm, symptomatic niche (primarily fertility problems) but also AUB, pelvic pain, dysmenorrhea |
Peng et al., 2022 ( |
China | Retrospective study | 24 | 23(LSC+HSC) | MFFS(35,9±2,3), FSG(32,6±5,2) | Muscle flap filling suture 1,1±0,3, Folding suture group 1,2±0,4) | NM | TVS | NM | MFFS 2,1±1,4, FSG 1,8±0,9 | MFFS 6,7±1,8, FSG 6,3±1,7 | TVS | NM | 3-30 | NM | NM | NM | Sonographic diagnosis of ishtmocele |
Fatehnejad et al., 2023 ( |
Iran | Retrospective cohort study | 99 | 45(LSC) | 38,4±4,7 | 1,47±0,55 | NM | TVS | 8,8(6,9-9,9) | TVS: 2,4(1,75-3,1) | Not measured | FU: interview | NM | 12 | 29,8±4,4 | NM | 12 | Symptomatic ishtmocele |
Nezhat et al., 2023 ( |
USA | Retrospective study | 27 | 23(LSC+HSC) | 36(27-45) | 1(n=20), |
25/45(55,5) | TVS/MRI/SIS/HSC | NM | NM | Not measured | FU: interview | NM | 1-36 | NM | 12/27(44) | 36 | Symptomatic niche |
Vissers et al., 2023 ( |
Netherlands | Prospective cohort study | 133 | 133(LSC+HSC) | 34±3,7 | 1(1-2) | 17/23(73,9) | TVS | 9,9(7,5-14,2) | 1(0,4-1,7) | Not measured | TVS | 6 | 24 | 46 | NM | 24 | Niche in the CS scar |
LSK, Laparoscopic; HSK, Hysteroscopic; ART, Artificial Reproductive Technology; CS, cesarean section; NM, not mentioned; IVF, In vitro fertilization; IUI, Intrauterine insemination; RMT, Residual Myometrial Thickness.
We identified one good-quality study (
Newcastle-Ottawa quality assessment form for cohort studies.
First author, Year of publication | Representativeness of exposed cohort | Selection of non-exposed cohort | Ascertainment of exposure | Outcome of interest not present at study start | Comparability of cohorts on the basis of the design or analysis controlled for confounders | Assessment of outcome | Sufficient length of follow-up for outcomes to occur | Adequacy of follow-up of cohorts | Total | Quality Assessment |
---|---|---|---|---|---|---|---|---|---|---|
Li et al., 2014 ( |
* | – | * | – | – | * | – | * | 3/8 | poor |
Donnez et al., 2017 ( |
* | – | * | * | – | * | * | – | 5/8 | poor |
Zhang, X et al., 2016 ( |
* | – | * | * | – | * | * | – | 5/8 | poor |
Delaine et al., 2017 ( |
* | – | * | – | – | * | * | * | 5/8 | poor |
Zhang, X. et al., 2017 ( |
* | – | * | – | – | * | * | – | 4/8 | poor |
Lv et al., 2018 ( |
* | – | * | * | – | – | * | – | 4/8 | poor |
Zhang, D. et al., 2019 ( |
* | – | * | – | * | – | * | * | 4/8 | poor |
Zhang, N. et al., 2021 ( |
– | – | – | – | * | – | * | * | 3/8 | poor |
Zhang,Y. et al., 2020 ( |
* | – | * | – | – | * | – | – | 3/8 | poor |
Karampelas et al., 2021 ( |
* | – | * | – | – | * | – | – | 3/8 | poor |
Cardaillac et al., 2023 ( |
* | – | * | – | – | * | * | – | 4/8 | poor |
Gulz et al., 2022 ( |
* | – | * | – | * | * | – | * | 5/8 | fair |
Jordans et al., 2022 ( |
– | * | * | – | * | * | – | * | 5/8 | fair |
Peng et al., 2022 ( |
* | – | * | – | – | * | * | – | 4/8 | poor |
Fatehnejad et al., 2023 ( |
* | – | * | – | – | * | – | – | 3/8 | poor |
Nezhat et al., 2023 ( |
* | – | * | – | – | * | * | * | 5/8 | fair |
Visser et al., 2023 ( |
* | – | * | * | * | * | * | * | 7/8 | good |
The included studies vary in design, population size, diagnostic methods, and outcome measures, highlighting the heterogeneity in isthmocele repair literature. The sample sizes range from small case series (
Of the included articles, 7 studies comprised infertile women with isthmocele (206 women). Five (
Summary results of the included studies: Reproductive outcomes in women with infertility after laparoscopic isthmocele repair.
First author, Year of publication | Time to conceive (mo) Mean (range) | Desire to get pregnant after surgery (Number/ Total) and % | Endometriosis (Number/ Total) and % | Conception mode (Spontaneous) (Number/ Total) and % | Conception mode (IUI) (Number/ Total) and % | Conception mode ( IVF) (Number/ Total) and % | Failed ART (Number/ Total) and % | Pregnant women (Number/ Total number) (%) | Miscarriage (Number/ Total) and % | Live birth (Number/ Total) and % | Delivery mode (Spontaneous (Number/ Total) and %) | Delivery mode (CS) (Number/ Total) and % | Complications during pregnancy/ delivery |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Li et al., 2014 ( |
NM | 3/3(100) | NM | NM | NM | NM | NM | 2/3(66,6) | NM | NM | NM | NM | NM |
Donnez et al., 2017 ( |
NM | 18/18(100) | 6/18(33,3) | NM | NM | NM | NM | 8/18(44) | 0/8(0) | 8/8(100) | 0/8(0) | 8/8(100) | 0 |
Delaine et al., 2017 ( |
9.5 | 4/4(100) | NM | 3/3(100) | 0 | 0 | 1/4(25) | 3/4 (75) | 0 | 3/3 (100) | 0 | 3/3(100) | 0 |
Karampelas et al., 2021 ( |
NM | 12/12(100) | NM | 10/10(100) | 0 | 0 | NM | 10/12(83,3) | NM | 6/6 | 0 | 6/6 | 0 |
Gulz et al., 2022 ( |
NM | 40/48(83,3) | 11/19(57,8) | NM | NM | NM | NM | 25/40(62,5) | 2/25(8) | 20/25(80) | NM | NM | NM |
Nezhat et al., 2023 ( |
NM | 15/23(65,2) | NM | 9/11(81,8) | 0 | 2/11(18,8) | NM | 11/15(73,3) | 2/15(13,3) | 9/15(60) | 1/9(11,1) | 8/9(88,88) | 0 |
Vissers et al., 2023 ( |
9 | 88/88(100) | NM | 16/53 (30) | 4/53(7,54) | 12/53(22,6) | NM | 53/88 (60,2) | 8/88 (81) | 47/53 (88) | 4/47(8,5) | 43/47(91,4) | 2(fetal loss), 3/4 premature delivery |
LSK, Laparoscopic; HSK, Hysteroscopic; ART, Artificial Reproductive Technology; CS, cesarean section; NM, not mentioned; IVF, In vitro fertilization; IUI, Intrauterine insemination.
Summary results of the included studies: Reproductive outcomes in women without infertility and unknown fertility after laparoscopic isthmocele repair.
First author, Year of publication | Time to conceive after Surgery (months) | Desire to get pregnant postoperative (Number/ Total) and % | Pregnant Women (Number/ Total) and % | Conception mode (Spontaneous) (Number/ Total) and % | Conception mode (IUI) (Number/ Total) and % | Conception mode (IVF) (Number/ Total) and % | Miscarriage (Number/ Total) and % | Induced Abortion (Number/ Total) and % | Live Birth (Number/ Total) and % | Pregnant during last Follow-up (Number/ Total) and % | Complications during pregnancy/ Delivery (Number/ Total) and % | Delivery mode (Spontaneous) (Number/ Total) and % | Delivery mode (CS) (Number/ Total) and % |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Li et al., 2014 ( |
NM | 4/38 |
4/6(66.6) | NM | NM | NM | NM | NM | 5/6(83.3) | 1/6(16.6) | NM | NM | NM |
Zhang, X. et al., 2016 ( |
NM | 32/86 |
12/32(37,5) | NM | NM | NM | 1/12(8,3) | 0/12(0) | 8/12(66,6) | 3/12(25) | NM | NM | NM |
Delaine et al., 2016 | NM | NM | 1/4(25) | 1/1(100) | 0/1(0) | 0/1(0) | 0/1(0) | 0/1(0) | 1/1(100) | 0/1(0) | 0/1(0) | 0/0(0) | 1/1(100) |
Zhang, X. et al., 2017 ( |
NM | 32/146 |
12/32(37,5) | NM | NM | NM | 1/12(8,3) | 1/12(8,3) | 10/12(83,3) | 0/12(0) | NM | 0/10(0) | 10/10(100) |
Lv et al., 2018 ( |
NM | 13/30 |
8/13(61,5) | NM | NM | NM | 5/8(62,5) | 0/8 |
3/8(37,5) | 0/8(0) | NM | 1/3(33,3) | 2/3(66,6) |
Zhang, D. et al., 2019 ( |
NM | 20/36 |
10/20(50) | NM | NM | NM | 5/10(50) | 0/10(0) | 5/10(50) | 0/10(0) | 0/10(0) | 1/5(20) | 4/5(80) |
Zhang, N. et al., 2020 | NM | 27/27 (100) | 8/27(29,6) | NM | NM | NM | 2/8(25) | 0/8 |
6/8(75) | 0/8(0) | 2/6(33,3) | 0/6(0) | 6/6(100) |
Zhang, Y. et al., 2020 ( |
NM | 36/43 (83.7) | 15/36(41.6) | NM | NM | NM | 1/15(6,6) | 0/15(0) | 6/15(40) | 8/15(53,3) | NM | NM | 6/6(100) |
Karampelas et al., 2021 ( |
NM | NM | 4/19(21,1) | 4/4 (100) | 0/4(0) | 0/4(0) | NM | NM | NM | NM | NM | NM | NM/4 |
Cardaillac et al., 2023 ( |
10.2 | 20/27 (74) | 15/20(75) | 9/15(60) | NM | NM | 1/15(6,6) | NM | 14/15(93,3) | 0/15(0) | NM | NM | NM |
Gulz et al., 2022 ( |
NM | NM | NM | NM | NM | NM | NM | NM | NM | NM | 7/38(18,4) | NM | NM |
Jordans et al., 2022 ( |
NM | NM | 61/61(100) | NM | NM | NM | NM | NM | 48/61(67.2) | 10/61 (16.3) | NM | NM | 48/48(100) |
Peng et al., 2022 ( |
NM | 11/23 |
10/11(90,9) | NM | NM | NM | 3/10(30) | 2/10(20) | 5/10(50) | 0 | NM | 0/5(0) | 5/5(100) |
Fatehnejad et al., 2023 ( |
NM | NM | 27/45(8,9) | NM | NM | NM | NM | NM | NM | NM | NM | NM | NM |
Vissers et al., 2023 ( |
9 | 45/45 (100) | 34/45(75,5) | 40/45(88,8) | 0/45(0) | 5/45(11,1) | 4/34 |
NM | 30/34(88,2) | 2 lost to follow up | NM | 0/45(0) | 30/30(100) |
LSK, Laparoscopic; HSK, Hysteroscopic; ART, Artificial Reproductive Technology; CS, cesarean section; NM, not mentioned; IVF, In vitro fertilization; IUI, Intrauterine insemination.
Preoperative diagnostic methods varied, with most studies utilizing transvaginal sonography (TVS), while some included additional imaging techniques such as MRI and saline infusion sonohysterography (
Residual myometrial thickness ranged from 2.5 mm to 5 mm in all women who underwent laparoscopic niche repair. The majority of studies have indicated that laparoscopic repair is the optimal approach when myometrial thickness is less than 3 mm, as this reduces the risk of perforating the bladder with the hysteroscopic approach. One study (
Endometriosis was reported in several studies, with prevalence rates ranging from 21% to 44% ( (
A meta-analysis of 17 studies comprising 309 women was conducted to evaluate reproductive outcomes in women after laparoscopic niche resection (
15 studies were eligible for inclusion in the analysis of CP, 12 in the analysis of MC, and 14 in the analysis of LB. After isthmocele repair, CP occurred in 44% (95% CI: 32-56%), MC in 15% (95% CI: 9-24%) and LB in 72% (95% CI, 61%–81%) (
Pooled overall prevalence of the effect of laparoscopic isthmocele repair reproductive outcomes. Forest plot of proportions and 95% confidence intervals (CI) for studies evaluating the prevalence of reproductive outcomes in women who underwent laparoscopic repair of the isthmocele. Blue squares for each study indicate the proportion, the size of the boxes indicates the weight of the study, and the horizontal lines indicate the 95% CI. The data in bold and pink diamond represent the pooled prevalence for post-treatment infertility and 95% CI. Overall estimates are shown in the fixed- and random-effect models. This pooled overall prevalence analysis evaluates three key variables:
The reproductive outcomes were stratified according to the fertility status (women with infertility, without infertility, and unknown fertility status) (
Pooled overall prevalence of the effect of laparoscopic isthmocele repair on reproductive outcomes in women with infertility. For details, see the legend of
Pooled overall prevalence of the effect of laparoscopic isthmocele repair on reproductive outcome in women without infertility. For details, see the legend of
Pooled overall prevalence of the effect of laparoscopic isthmocele repair of the reproductive outcome in women with unknown fertility status. For details, see the legend of
Five studies were eligible for the analysis of the pooled prevalence of endometriosis diagnosed during isthmocele repair. The analysis showed an overall prevalence of endometriosis of 29% (95% CI, 22%-37%). The heterogeneity test showed low heterogeneity between studies I2 = 32, p < 0.01 (
Pooled overall prevalence of endometriosis in women during laparoscopic isthmocele repair. Forest plot of proportions and 95% confidence intervals (CI) for studies evaluating the prevalence of endometriosis in women undergoing laparoscopic isthmocele repair. Blue squares for each study indicate the proportion, the size of the boxes indicates the weight of the study, and the horizontal lines indicate the 95% CI. The data in bold and pink diamond represent the pooled prevalence for post-treatment infertility and 95% CI. Overall estimates are shown in the fixed- and random-effect models. This pooled overall prevalence analysis evaluates three key variables:
The aim of this study was to evaluate the effect of laparoscopic isthmocele repair on reproductive outcomes. Given the recent increase in cesarean section rates and potential long-term complications, considerable attention has been given to evaluating whether surgery has the potential to improve reproductive outcomes among women with isthmoceles.
Our review revealed the positive effect of laparoscopic isthmocele resection on reproductive outcomes, with the following key findings: First, 44% of women experienced CP after isthmocele repair, while LB was notably high at 72%, with all pregnant women as the reference denominator. Second, women with infertility had the highest rates of CP (62%; 95% confidence interval (CI): 54–69%) and LB (72%; 95% CI: 54–85%) compared to women without infertility (CP: 33%, 95% CI: 16–57%/LB: 78%, 95% CI: 46–94%) and women with unknown fertility status (CP: 36%, 95% CI: 21–55%/LB: 61%, 95% CI: 42–77%). Third, the prevalence of endometriosis at surgery was 29% (95% CI: 22–37%).
Although our study strictly followed the recommendations to provide high-quality evidence summaries, some limitations are evident. First, most of the included studies were based on retrospective data, resulting in high statistical heterogeneity. Second, there was a lack of data regarding inconsistency, poor description of other relevant causes of infertility, no information on the time until pregnancy, and a lack of data regarding fertilization methods. Third, another limitation of the included studies is that they did not exclusively include women with secondary infertility, but also women who presented with difficulties in embryo transfer or had other bleeding disturbances. This broader patient population may introduce variability in the results and limit the ability to generalize the findings specifically to women with secondary infertility. Thus, we could not perform sub-analyses of cases requiring ART. Fourth, some studies did not justify the choice of treatment, and there was a paucity of information regarding the cesarean scar defect or magnetic resonance imaging following surgery.
Infertility with isthmocele was significantly higher than without (66% vs 46%; p=0.03) (
One mechanism that could explain the association between isthmocele and infertility, particularly in patients undergoing ART, is the alteration of the endometrial environment due to hemorrhagic disturbances. Residual and abnormal bleeding caused by the isthmocele creates an environment that is less receptive to embryo implantation, as it interferes with the synchronization between the endometrial phase and embryo transfer. Furthermore, the presence of isthmocele may complicate embryo transfer, further exacerbating the challenges for achieving successful implantation. This disruption affects the quality and stability of the endometrium, significantly compromising reproductive outcomes (
Our study revealed that isthmocele repair led to a 44% CPR and a 72% LBR (having all pregnant women as the denominator), suggesting that while implantation may be initially impaired, pregnancy maintenance improves significantly. Endometrial alterations, including residual bleeding and structural anomalies, likely create a less receptive environment for embryo implantation (
In a recent systematic review and meta-analysis (
However, as laparoscopic surgical repair is a non-standardized treatment, the quality of studies on this topic is heterogeneous. Only one included study had good quality (
There is a complete lack of randomized controlled trials comparing the effect of isthmocele repair on reproductive outcome parameters with control groups without surgical intervention. So far, the LAPRES trial (Dutch Trial Register (ref. no. NL6350
Reproductive outcome analysis in infertile patients after isthmocele repair, as performed in our study, is currently the only strategy to assess the impact of surgical interventions on reproductive outcomes. Notably, none of the selected studies specifically reported on the mode of conception of subsequent pregnancy among women with previous failed ART before surgery. Nezhat et al. (
Five studies advised patients to wait at least three months before attempting conception after surgery. Conversely, 2 studies suggest a waiting period of 1 year before trying again (
A key aspect of the surgical approach is that laparoscopy has the added advantage of simultaneous diagnosis and treatment of other potential causes of infertility (
Endometriosis was found in 27% of patients with isthmocele who underwent laparoscopic resection in a retrospective study by Gulz et al. (
Considering the availability of different treatment options and the lack of clinical guidelines on this issue, consideration should be given to ultrasound of the residual myometrial thickness, the presence of other pathologies (e.g., endometriosis, adhesions, tubal obstruction, etc.), as well as the patient’s symptoms before deciding on a management approach. If surgical treatment is indicated, the choice between a hysteroscopic resection and laparoscopic or vaginal repair should be based on factors such as the residual myometrial thickness and the skills of the surgeon (
Furthermore, Verberkt et al. recommended that future studies should examine the effects of uterine-niche-related surgery (
Laparoscopic repair of isthmoceles is associated with good reproductive outcomes, suggesting this intervention is effective. Women with a history of infertility may benefit. However, further Randomized Controlled Trials are required to provide robust evidence to support this hypothesis.
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/
AV: Conceptualization, Data curation, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing. JG: Conceptualization, Data curation, Methodology, Supervision, Writing – review & editing. VV: Data curation, Methodology, Software, Writing – review & editing. JP: Data curation, Formal analysis, Methodology, Writing – review & editing. MG: Methodology, Supervision, Writing – review & editing. TK: Conceptualization, Data curation, Investigation, Methodology, Software, Writing – review & editing. MM: Validation, Writing – review & editing. Mv: Conceptualization, Funding acquisition, Supervision, Visualization, Writing – review & editing.
The author(s) declare that financial support was received for the research and/or publication of this article. The Institute Biochimique SA, Lugano, Switzerland, supported the study with an unrestricted grant, which did not play any role in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declare that no Generative AI was used in the creation of this manuscript.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
The Supplementary Material for this article can be found online at:
Database Search Strategies. A systematic literature search in Medline, Embase, and Cochrane CENTRAL.